Drugplain

Nicotine transdermal system 7 mg/24h

nicotine · PATCH, EXTENDED RELEASE · Target Corporation

No Recall History
Plain English

Nicotine transdermal system is a patch, extended release containing nicotine at 7 mg/24h, taken transdermal. Manufactured by Target Corporation.

Key Facts

Brand Name
Nicotine transdermal system
Generic Name
nicotine
NDC Code (Product)
11673-196
Manufacturer
Target Corporation
Strength
7 mg/24h
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Marketing Status
Application #
NDA020165
Drug Class
Cholinergic Nicotinic Agonist [EPC]
Marketing Start
02/16/2000

Recall History

No Recall History

Frequently Asked Questions

What is Nicotine transdermal system used for?

Nicotine transdermal system contains nicotine. It is a patch, extended release taken transdermal. Consult your doctor for specific uses.

Is Nicotine transdermal system a controlled substance?

Nicotine transdermal system is not classified as a controlled substance by the DEA.

What is the generic name for Nicotine transdermal system?

The generic name for Nicotine transdermal system is nicotine. There are 12 other brand versions of nicotine.

What is the NDC code for Nicotine transdermal system 7 mg/24h?

The NDC (National Drug Code) for Nicotine transdermal system 7 mg/24h is 11673-196, listed by Target Corporation.